Medpace Holdings, Inc. Sustainability Profile
Medpace Holdings, Inc., a leading global clinical research organisation, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1992, Medpace has established itself as a trusted partner in the pharmaceutical and biotechnology industries, specialising in full-service clinical development and regulatory consulting. The company offers a comprehensive range of services, including clinical trial management, data management, and biostatistics, which are tailored to meet the unique needs of its clients. Medpace's commitment to quality and efficiency has positioned it as a preferred choice for sponsors seeking to navigate the complexities of clinical trials. With a strong track record of successful project delivery and a focus on therapeutic expertise, Medpace Holdings, Inc. continues to achieve significant milestones, solidifying its reputation as a key player in the clinical research landscape.
DitchCarbon Score
How does Medpace Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medpace Holdings, Inc.'s score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medpace Holdings, Inc.'s reported carbon emissions
Medpace Holdings, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no specific figures regarding their carbon emissions in kg CO2e, nor any inherited data from a parent or related organization. In the absence of concrete emissions data or reduction commitments, it is unclear how Medpace Holdings, Inc. is addressing climate change within its operations. The company may need to establish clearer climate strategies and reporting mechanisms to align with industry standards and expectations for sustainability.
How Carbon Intensive is Medpace Holdings, Inc.'s Industry?
How Carbon Intensive is Medpace Holdings, Inc.'s Location?
Medpace Holdings, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medpace Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
